• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Newsletter Sign Up
Contact
  • Home
  • News
  • News
  • Annual Report on New Drug Clinical Trial Applications in 2020

Annual Report on New Drug Clinical Trial Applications in 2020

Monday, 20 December 2021 / Published in News, NMPA Registration in China, Pharmaceuticals & DMF

Annual Report on New Drug Clinical Trial Applications in 2020

On November 10, 2021, the CDE (Center for Drug Evaluation) under the NMPA (National Medical Products Administration) published the annual report on clinical trial applications for new drug products registered in 2020. The online drug platform received a total of 2602 clinical trial applications in 2020 with an increase of 9.1% as compared to 2019.

According to the report, 1473 applications were for new drugs and 1129 applications were for generic drugs. Under the new drug category, 801 applications (73.6%) were for chemical drugs, 605 applications (23.8%) were for biological products, and 67 applications (4.5%) were chinese medicine and natural drug products.

Although the report points out problem such as homogenization in drug clinical trials, inefficient implementation of clinical trials after approvals, etc., there is still an increasing demand of clinical trial applications for drugs in China.

By Sun Jinlin and Jacky Li. Contact Cisema if you would like to learn more.

Tagged under: chemical drugs, drug clinical trial, drugs, new drugs

What you can read next

First Hong Kong Medical Device Approved for Clinical Use in the Greater Bay Area
Radio Frequency Beauty Devices will be regulated as Medical Devices Soon
CMDE Platform for AI Medical Device
CMDE Platform for AI Medical Device 2nd Committee Meeting in 2022

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • GB9706 standards for medical electrical equipment

    GB9706 standards for medical electrical equipment – implementation details clarified

    GB9706 standards are important reference guidel...
  • Microbial limits for non-sterile chemical drugs

    Microbial limits for non-sterile chemical drugs, API and excipients – new guidelines issued

    Microbial limits for non-sterile chemical drugs...
  • Medical Device Supplementary Notice Period

    China’s Medical Device Supplementary Notice Period reverts to a one-year period

    China’s Medical Device Supplementary Notice Per...
  • Dental adhesive products registration review guidelines

    Dental adhesive products registration review guidelines issued by the CMDE

    Dental adhesive products registration review gu...
  • China’s Toothpaste Supervision & Administration Regulation

    China’s New Toothpaste Supervision & Administration Regulation: A brief guide

    China’s Toothpaste Supervision & Administra...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2021 Cisema. All rights reserved.

TOP